Jagsonpal Pharmaceuticals to acquire India business of Resilient Cosmeceuticals

22 Feb 2025 Evaluate

Jagsonpal Pharmaceuticals has signed a Business Transfer Agreement to acquire the India business of Resilient Cosmeceuticals for a cash consideration of Rs 24 crore, to be funded from internal accruals. The company had a cash balance of Rs 132 crore as on December 31, 2024. 

The transaction is subject to customary closing conditions and is expected to close within 45 days. The acquisition gives access to a complimentary portfolio of Pharmaceuticals, Nutritional and Cosmetic products tapping into around Rs 1000 crore market opportunity in India.

Jagsonpal Pharmaceuticals is among India’s premiere pharmaceutical companies. The company has substantial research and development, manufacturing, marketing and distribution facilities. 


Jagsonpal Pharma Share Price

215.95 -7.85 (-3.51%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...